Navigation Links
/C O R R E C T I O N -- Rosetta Genomics Ltd/
Date:5/21/2008

27

Additional paid-in capital 59,201 58,984

Other comprehensive income 28 86

Deficit accumulated during the

development stage (39,370) (35,492)

Total shareholders' equity 19,886 23,605

Total liabilities and shareholders'

equity $ 22,594 $ 26,038

ROSETTA GENOMICS LTD. AND ITS SUBSIDIARY

(A development stage company)

CONSOLIDATED STATEMENTS OF OPERATIONS

U.S. dollars in thousands (except share and per share data)

Three months

Year ended December 31, ended March 31,

2007 2006 2008 2007

Unaudited

Operating expenses:

Research and development, net $ 6,400 $ 4,781 $ 2,389 $ 1,161

Marketing and business

development 1,742 1,504 511 375

General and administrative 2,903 1,860 829 680

Operating loss 11,045 8,145 3,729 2,216

Financial expenses (income),

net 3,616 (538) 149 (200)

Net loss $ 14,661 $ 7,607 $ 3,878 $ 2,016

Basic and diluted net loss

per Ordinary share $ 1.32 $ 2.98 $ 0.33 $ 0.23

Weighted average number of

Ordinary shares used to

compute basic and diluted

net loss per Ordinary share 11,142,149 2,551,860 11,920,401 8,874,841

Contact: Media

Rachel Spielman

T: +1-212-583-2714

E:

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how latent viruses ... is the Epstein Barr Virus (EBV), and one of these ... chronic inflammatory disease that destroys the body’s joints. As predicted ... high concentrations of EBV DNA in their bodies (1). ...
(Date:1/15/2014)... 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today ... R-Pharm, a leading Russian pharmaceutical company, to develop and ... Russian Federation , Turkey ... is a novel antibiotic for the treatment of bacterial ...
(Date:1/14/2014)... As pet owners drew up their lists of New Year,s ... better care of my furry companion." Nowadays there are pet salons, ... cases to take the little canine or feline darlings along wherever ... buy some pricey toys at the pet store. But anyone who ...
(Date:1/14/2014)... In recent years, growing suspicion about ... product development and promotion has led to unprecedented levels ... by concerns about the insidious impact of commercialization of ... fines to the world’s biggest pharmas for illegal marketing ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... mechanical and electrical properties, carbon nanotubes are ... including high-performance sensors, logic devices, and memory ... creating well-ordered arrays of individual carbon nanotubes ... prevented any large-scale commercial use. Now, ...
... Dec. 7, 2010 Sangamo BioSciences, Inc. (Nasdaq: ... demonstrate the ability to permanently correct a disease gene in ...  The presentation was one of four made by Sangamo,s collaborators ... Hematology (ASH), which is being held in Orlando, Florida.   ...
... Cellectis bioresearch, the specialist in genome customization and subsidiary ... signed a non-exclusive agreement with Evrogen (Moscow, Russia) for ... bioresearch to incorporate these proteins into its own products ... tools. Luc Selig, Sales and Marketing ...
Cached Biology Technology:Using new materials to make more reliable nanoelectromechanical systems 2Sangamo BioSciences Announces Data Presentation of First In Vivo Demonstration of ZFN-mediated Gene Correction Via Systemic Delivery at American Society for Hematology Meeting 2Sangamo BioSciences Announces Data Presentation of First In Vivo Demonstration of ZFN-mediated Gene Correction Via Systemic Delivery at American Society for Hematology Meeting 3Sangamo BioSciences Announces Data Presentation of First In Vivo Demonstration of ZFN-mediated Gene Correction Via Systemic Delivery at American Society for Hematology Meeting 4Cellectis bioresearch Signs Non-Exclusive License With Evrogen for Access to Fluorescent Proteins 2Cellectis bioresearch Signs Non-Exclusive License With Evrogen for Access to Fluorescent Proteins 3
(Date:4/17/2014)... devastate honeybees in Europe, Asia and the United States ... to be impacting native honeybee populations at this time, ... pests include including Nosema microsporidia and ... be resilient to these invasive pests, which suggests to ... Europe, Asia and the United States currently are not ...
(Date:4/17/2014)... such as heart disease, epilepsy and pain, making them ... is still much scientists do not know about the ... into the structure of sodium channels and, specifically, one ... responsible for ,fine-tuning, the activity of the channel. The ... the Journal of Biological Chemistry . , Nerves ...
(Date:4/17/2014)... Ind. -- Indiana University researchers have detected new early-warning ... diabetes. This discovery could have far-reaching implications for the ... care of over 25 million Americans. , "We had ... retinas at such early stages," said Ann Elsner, professor ... and lead author of the study. "We set out ...
Breaking Biology News(10 mins):East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3Structure of sodium channels different than previously believed 2New technique detects microscopic diabetes-related eye damage 2New technique detects microscopic diabetes-related eye damage 3
... into our brain, and new research by University of ... known that fear and other highly emotional experiences lead ... today (Tuesday, June 14) in advance of publication in ... Kaufer and colleagues report a new way for emotions ...
... , This release is available in Spanish ... mixes are a produce section favorite. They offer convenience, selection, ... from the chore of washing and chopping, slicing, or shredding ... time to time, been associated with bagged salad greens. The ...
... to replace lost teeth with titanium dental implants could be ... only at micro level but also at nano level, researchers ... a method that could shorten the healing time for patients. ... the conductivity of the implant allows us to affect the ...
Cached Biology News:Fear boosts activation of young, immature brain cells 2Fear boosts activation of young, immature brain cells 3Scientists pitch in to help keep salad mixes safe to eat 2Healing times for dental implants could be cut 2
... 200RT rotary tables offer precision motorized rotation ... compatible with Parkers linear positioners and its ... multi-axis configurations., , Preloaded, precision worm ... Dual race preloaded angular contact support bearing ...
Anti-Mouse Macrophages (Metallophillic), Purified (Clone MOMA-1) (rat IgG2a)...
Human Osteocalcin (1-22) mature form. Also reacts with Osteocalcin (1-44) and Osteocalcin (1-49). No reactivity with Bone sialoprotein....
1/4" to 1/8" Adapter for Reflectance Probe Holder...
Biology Products: